Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain

Neurobiology of Disease

Volumn 3, Issue 1, 1996, Pages 51-63

  Stephenson, Diane T ^a   Lemere, Cynthia A ^b   Selkoe, Dennis J ^b   Clemens, James A ^a  

^a ELI LILLY AND COMPANY   (United States)

^b Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PHOSPHOLIPASE A2; ARACHIDONIC ACID; BIOLOGICAL MARKER; ISOENZYME; NERVE PROTEIN; PHOSPHOLIPASE A;

ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CEREBELLUM; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; OCCIPITAL CORTEX; PRIORITY JOURNAL; ADULT; AGED; ASTROCYTE; BRAIN; BRAIN CORTEX; ENZYME ACTIVATION; ENZYME IMMUNOASSAY; ENZYMOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ARACHIDONIC ACID; ASTROCYTES; BIOLOGICAL MARKERS; BRAIN; CEREBELLUM; CEREBRAL CORTEX; CYTOSOL; ENZYME ACTIVATION; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; ISOENZYMES; NERVE TISSUE PROTEINS; PHOSPHOLIPASES A; SIGNAL TRANSDUCTION;

EID: 0029657725     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1996.0005     Document Type: Article

References (70)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
2. Aisen, P. S., & Davis, K. L. (1994) Inflammatory mechanisms in Alzheimer's disease: Implications for therapy. Am. J. Psych. 151, 1105-1113.
3. Araujo, D. M., & Cotman, C. W. (1992) β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 569, 141-145.
4. 2 via GTP-binding proteins: Arachidonic acid and its metabolites as second messengers. Trends Neurosci. 11, 117-123.
5. Basso, D., Fabris, C., Panozzo, M. P., Meggiato, T., Favoro, G. E., & Naccarato, R. (1990) Serum phospholipase A2 activity in chronic pancreatic diseases. Clin. Biochem. 23, 229-232.
6. Beach, T. G., Walker, R., & McGeer, E. G. (1989) Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 2, 420-436.
7. Benveniste, E. N. (1992) Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action. Am. J. Physiol. 263 (Cell Physiol. 32), C1-C16.
8. Berkenbosch, F., Refolo, L. M., Friedrich, V. L., Casper, D., Blum, M., & Robakis, N. K. (1990) The Alzheimer's amyloid precursor protein is produced by type I astrocytes in primary cultures of rat neuroglia. J. Neurosci. Res. 25, 431-440.
9. Bosisio, E., Galli, C., Galli, G., Nicosia, S., Spangnuolo, C., & Tosi, L. (1976) Correlation between release of free arachidonic acid and prostaglandin formation in brain cortex and cerebellum. Prostaglandins 11, 773-781.
10. Boyles, J. K., Pitas, R. E., Wilson, E., Mahley R. W., & Taylor, J. M. (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76, 1501-1513.
11. Breitner, J. C. S., Gau, B. A., Welsh, K. A., Plassman, B. L., McDonald, W. M., Helms, J. J., & Anthony, J. C. (1994) Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study. Neurology 44, 227-232.
12. Chen, J., Engle, S. J., Seilhamer, J. J., & Tischfield, J. A. (1994) Cloning and characterization of novel rat and mouse low molecular weight Ca(2+)-dependent phospholipase A2s containing 16 cysteines. J. Biol. Chem. 269, 23018-23024.
13. Clark, J. D., Lin, L. L., Driz, R. W., Ramesha, C. S., Sultzman, L. A., Lin, A. Y., Milona, N., & Knopf, J. L. (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a CA(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65, 1043-1051.
14. 2 following transient global forebrain ischemia in the rat. Stroke, 27, 527-535.
15. Cole, G. M., Masliah, E., Shelton, E. R., Chan, H. W., Terry, R. D., & Saitoh, T. (1991) Accumulation of amyloid precursor fragment in Alzheimer plaques. Neurobiol. Aging 12, 85-91.
16. Dani, J. W., Chernjavsky, A., & Smith, S. J. (1992) Neuronal activity triggers calcium waves in hippocampal astrocyte networks. Neuron 8, 429-440.
17. Davidson, F. F., & Dennis, E. A. (1990) Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms. J. Mol. Evol. 31, 228-238.
18. Duffy, P. E., Rapport, M., & Graf, L. (1980) Glial fibrillary acidic protein and Alzheimer-type dementia. Neurology 30, 778-782.
19. Eikelenboom, P., Zhan, S-S., van Gool, W. A., & Allsop, D. (1994) Inflammatory mechanisms in Alzheimer's disease. Trends Pharm. Sci. 15, 447-450.
20. 2 activation influences the processing and secretion of the amyloid precursor protein. Biochem. Biophys. Res. Commun. 197, 292-297.
21. 2 activity in Alzheimer's brains. Biol. Psych. 37, 13-17.
22. Games, D., Adams, D., Alessandrini, R., Barbour, R., et al., (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
23. 2 by phosphorylation in rat mesangial cells. J. Clin. Invest. 93, 1224-1233.
24. Gross, R. W. (1992) Myocardial phospholipase A2 and their membrane substrates. Trends Cardiovascular Med. 2, 115-121.
25. Haass, C., Hung, A. Y., & Selkoe, D. J. (1991) Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J. Neurosci. 11, 3783-3793.
26. Haas, C., Koo, E. H., Mellon, A., Hung, A. Y., & Selkoe, D. J. (1992) Targeting of cell-surface beta-amyloid precursor protein to lysosomes: Alternative processing into amyloid-bearing fragments. Nature 357(6378), 500-503.
27. Iwamoto, N., Kobayashi, K., & Kosaka, K. (1989) The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients. J. Neurol. 236, 80-84.
28. 2 in breast carcinoma cells. Oncogene 10, 2297-2305.
29. Jeandel, C., Nicolas, M. B., Dubois, F., Nabet-Belleville, F., Penin, F., & Cuny, G. (1989) Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35, 275-282.
30. Jenkinson, M. L., Bliss, M. R., Brain, A. T., & Scott, D. L. (1989) Rheumatoid arthritis and senile dementia of the Alzheimer's type. Br. J. Rheumatol. 28, 86-88.
31. Khachaturian, Z. S. (1985) Diagnosis of Alzheimer's disease. Arch. Neurol. 42, 1097-1105.
32. Kalaria, R. N. (1993) The immunopathology of Alzheimer's disease and some related disorders. Brain Pathol. 3, 333-347.
33. Karli, U. O., Schafer, T., & Burger, M. M. (1990) Fusion of neurotransmitter vesicles with target membrane is calcium independent in a cell-free system. Proc. Natl. Acad. Sci. USA 87, 5912-5915.
34. Kinouchi, T., Ono, Y., Sorimachi, H., Ishiura, S., & Suzuki, K. (1995) Arachidonate metabolites affect the secretion of an N-terminal fragment of Alzheimer's disease amyloid precursor protein. Biochem. Biophys. Res. Commun. 209, 841-849.
35. 2. In: Advances in Second Messenger and Phosphoprotein Research (P. Greengard & A. Robinson, Eds.), Vol. 28, pp. 81-89. Raven Press, NY.
36. Kramer, R. M., Hession, C., Johansen, B., Hayes, G., McGray, P., Chow, E. P., Tizard, R., & Pepinsky, R. B. (1990) Structure and properties of a human non-pancreatic phospholipase A2. J. Biol. Chem. 264, 5768-5775.
37. 2 is a 100-kDa protein in human monoblast U937 cells. J. Biol. Chem. 266, 5268-5272.
38. 2) in human platelets. J. Lipid Mediators 6, 209-216.
39. 2 in human fibroblasts. J. Biol. Chem. 267, 23451-23454.
40. Lue, L-F., & Rogers, J. (1992) Full complement activation fails in diffuse plaques of the Alzheimer's disease cerebellum. Dementia 3, 308-313.
41. 2+ in Alzheimer's disease. Trends Neurosci. 16, 409-414.
42. McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16, 516-527.
43. McGeer, P. L., McGeer, E., Rogers, J., & Sibley, J. (1990) Anti-inflammatory drugs and Alzheimer disease. Lancet 335, 1037.
44. Minami, T., Tojo, H., Shinomura, Y., Komatsubara, T., Matsuzawa, Y., & kamoto, M. (1993) Elevation of phospholipase A2 protein in sera of patients with Crohns disease and ulcerative colitis. Am. J. Gastroenterol. 88, 1076-1080.
45. Nedergaard, M. (1994) Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 263, 1768-1770.
46. Negre-Aminou, P., & Pfenninger, K. H. (1993) Arachidonic acid turnover and phospholipase A2 activity in neuronal growth cones. J. Neurochem. 60, 1126-1136.
47. Nitsch, R. M., Blusztajn, J. K., Pittas, A. G., Slack, B. E., Growdon, J. H., & Wurtman, R. J. (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA 89, 1671-1675.
48. 2 gene in rat C6 glioma cell line. Biochem. Biophys. Res. Commun. 205, 12-17.
49. Palmert, M. R., Podlisny, M. R., Witker, D. S., Oltersdorf, T., Younkin, L. H., Selkoe, D. J., & Younkin, S. G. (1988) Antisera to an amino-terminal peptide detect the amyloid precursor protein of Alzheimer's disease and recognize senile plaques. Biochem. Biophys. Res. Commun. 156, 432-437.
50. Peterson, C., Ratan, R., Shelanski, M., & Goldman, J. (1989) Changes in calcium homeostasis during aging and Alzheimer's disease. Ann. NY Acad. Sci. 568, 262-270.
51. Pettegrew, J. W., McClure, R. J., Kanfer, J. N., Mason, R. P., Panchalingam, K., & Klunk, W. E. (1994) The role of membranes and energetics in Alzheimer Disease. In: Alzheimer Disease (R. D. Terry, R. Katzman, & K. L. Bick, Eds.) pp. 369-386. Raven Press, New York.
52. Pike, C. J., Cummings, B. J., & Cotman, C. W. (1995) Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp. Neurol. 132, 172-179.
53. Pike, C. J., Cummings, B. J., Monzavi, R., & Cotman, C. W. (1995) Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63, 517-531.
54. Potter, H. (1992) The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease. Prog. Brain Res. 94, 447-458.
55. Pruzanski, W., Vadas, P., Stefanski, E., & Urowitz, M. B. (1985) Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. J. Rheumatol. 12, 211-216.
56. Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., Ward, P., & Lieberburg, I. (1992) Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 89, 10016-10020.
57. Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., McGeer, P. L., Kaszniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Wilson, P., & Kogen, F. (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43, 1609-1611.
58. Roth, G. S., Joseph, J. A., & Mason, R. P. (1995) Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. Trends Neurosci. 18, 203-206.
59. Rozemuller, J. M., Stam, F. C., & Eikelenboom, P. (1990) Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease. Neurosci. Lett. 119, 75-78.
60. Seilhamer, J. J., Randall, T. L., Johnson, L. K., Heinzmann, C., Klisak, I., & Sparkes, R. S. (1989) Novel gene exon homologous to pancreatic phospholipase A2: Sequence and chromosomal mapping of both human genes. J. Cell Biol. 39, 327-337.
61. Selkoe, D. J. (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.
62. Shea, T. B., Beermann, M. L., Honda, T., & Nixon, R. A. (1994) Secretion of amyloid precursor protein and laminin by cultured astrocytes is influenced by culture conditions. J. Neurosci. Res. 37, 197-207.
63. 2) is expressed in human brain astrocytes. Brain Res. 637, 97-105.
64. Su, J. H., Anderson, A. J., Cummings, B. J., & Cotman, C. W. (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 5, 2529-2533.
65. Subbarao, K. V., Richardson, J. S., & Ang, L. C. (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55, 342-345.
66. Vadas, P. J., & Pruzanski, W. (1993) Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome. Circ. Shock 39, 160-167.
67. Vijayan, V. K., Geddes, J. W., Anderson, K. J., Chui, H. C., Ellis, W. G., & Cotman, C. W. (1991) Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation. Exp. Neurol. 112, 72-78.
68. Woelk, H., & Porcellate, G. (1973) Subcellular distribution and kinetic properties of rat brain phospholipases A1 and A2. Hoppe-Seylers A Physiol Chem. 354, 90-100.
69. Wolfe, L. S. (1975) In: Advances in Neurochemistry: Possible Role of Prostaglandins in the Nervous System (B. W. Agranoff & M. H. Aprison, Eds.) p. 1. Plenum, London.
70. Yamaguchi, H., Yamazaki, T., Ishiguro, K., Shoji, M., Nakazato, Y., & Hirai, S. (1992) Ultrastructural localization of Alzheimer amyloid β/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes. Acta Neuropathol. 85, 15-22.